eClinical Solutions Market Size to Surpass USD 20.8 BN by 2030

According to Report, the global eclinical solutions market size is predicted to surpass around USD 20.8 billion by 2030 from valued at USD 6.2 billion in 2020, registering a CAGR of 12.6% from 2022 to 2030.

Increasing R&D activities by biopharma and pharma companies, application of software solutions in clinical trials, and expanding customer base are anticipated to fuel market growth. During the COVID-19 pandemic, clinical laboratories experienced high demand for COVID-19 tests. eClinical solutions, such as the clinical data management systems assisted these laboratories to seamlessly manage the huge influx of specimens daily. Technological advancements such as electronic data capture and Wi-Fi connectivity are projected to drive the market in the forthcoming years.

Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/39114

Increasing research and development activities by biopharma and pharma companies is one of the key trends escalating market growth. Besides this, the growing incorporation of software solutions in clinical trials is also projected to provide a fillip to the market. The COVID-19 pandemic boosts the adoption of the market, as companies in the market were investing in better healthcare IT solutions to help in tackling the pandemic.

Report Coverage

By Product Analysis

The CTMS segment dominated the market for eClinical solutions and accounted for the largest revenue share of over 21.0% in 2021. eCOA is estimated to be the fastest-growing segment during the forecast period owing to the rising significance of high-quality clinical data. 

Soaring need for patient compliance is further pushing the usage of eCOA solutions, which can effectively meet challenges posed by paper-based records. Elimination of data variance risk streamlined information and lowering of site monitoring cost are key advantages associated with eCOA. 

By Delivery Mode Analysis

The web-hosted segment dominated the market for eClinical solutions and accounted for the largest revenue share of over 74.0% in 2021. The dominance of the segment can be attributed to associated benefits such as easy accessibility, usability, and lower investments required.

The cloud-based segment is anticipated to exhibit an exponential CAGR of 15.1% during the forecast period owing to integrated features such as flexibility, high accessibility, negligible handling costs, and easy data backup.

Ask here for more details@ https://www.visionresearchreports.com/report/enquiry/39114

By Development Phase Analysis

The phase III segment dominated the eClinical solutions market and accounted for the largest revenue share of over 53.0% in 2021. Spiraling needs for incorporation of clinical data management software to curb overall cost and improve process efficiency is contributing to the growth of the segment.

The phase I segment is estimated to be the most promising segment during the forecast period owing to the high significance of these systems to predict future outcomes and eliminate drug candidates possessing the least probability of success.

By End-use Analysis

The CROs segment dominated the market for eClinical solutions and held the largest revenue share of over 36% in 2021. The segment is projected to rise at a remarkable CAGR during the forecast period owing to the growing inclination of pharmaceutical companies to reduce overall expenditure. 

The rising usage of eClinical solutions in research is further widening the scope of segment growth. Benefits involved in outsourcing clinical trials to CROs are responsible for the heightened growth of this segment.

The pharma and biotech organizations segment is expected to witness significant growth over the forecast period. This is attributed to the increasing adoption of eClinical solutions by researchers that provide improved clinical trials and streamlined research workload.

By Regional Analysis

North America dominated the market for eClinical solutions and accounted for the largest revenue share of over 51% in 2021. An increasing target population, coupled with the rising prevalence of lifestyle-associated diseases such as diabetes and cardiac disorders, is poised to stimulate the growth of the market.

In Asia Pacific, the market for eClinical solutions is likely to register a noteworthy CAGR at 15.4% over the forecast period. High unmet medical needs and the rising prevalence of target chronic diseases such as cancer, cardiovascular conditions, and infectious diseases are stoking the demand for software solutions in the region.

Key Players

• Datatrak International, Inc.
• Oracle
• Parexel International Corporation
• Dassault Systemes
• Bioclinica
• CRF Health
• ERT Clinical
• eClinicalWorks
• IBM Watson Health
• Anju Life Sciences Software
• eClinical Solutions

Market Segmentation

• By Product 
  • Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS) 
  • Clinical Trial Management Systems (CTMS)
  • Clinical Analytics Platforms
  • Randomization and Trial Supply Management (RTSM) 
  • Clinical Data Integration Platforms
  • Electronic Clinical Outcome Assessment (eCOA)
  • Safety Solutions
  • Electronic Trial Master File (eTMF)
• By Delivery Mode 
  • Web-hosted (On demand)
  • Licensed Enterprise (On premise)
  • Cloud-based
• By Development Phase 
  • Phase I
  • Phase II
  • Phase III
  • Phase IV
• By End-use
  • Hospitals/Healthcare providers
  • CROs
  • Academic Institutes
  • Pharma & Biotech Organizations
  • Medical Device Manufacturers
• Regional
  • North America
  • Europe
  • Asia Pacific
  • Central & South America
  • Middle East & Africa

Click Here to View Full Report Table of Contents

Full Report is Ready | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/39114

You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333